Table 3.
Opioida | Main mode of action | Attributes | Precaution | Typical starting dose |
---|---|---|---|---|
Tramadol | μ-Opioid receptor agonist, 5HT- and NOR-reuptake blocker | Less constipation than other opioids | Nausea should be prevented by antiemetics; analgesia impaired in CYP2D6 poor metabolizers | 25–50 mg q 4–6 h (IR); 50–100 mg q 12 h (CR) |
Dihydrocodeine | μ-Opioid receptor agonist | Useful for patients with moderate pain, cough, and dyspnea | Constipation should be prevented by laxatives | 30 mg q 4–6 h (IR); 60 mg q 12 h (CR) |
Codeine | μ-Opioid receptor agonist | Useful for patients with moderate pain, cough, and dyspnea; combined formulations with paracetamol | Constipation should be prevented by laxatives; should not be administered in CYP2D6 ultrarapid metabolizers | 30 mg q 4–6 h (IR); 60 mg q 12 h (CR) |
aTaken orally
5HT Serotonin; CR Controlled-release formulations; CYP2D6 Cytochrome P450 2D6; IR Immediate-release formulations; NOR Noradrenaline; q Every